Search results
Pfizer And Five Other Dividend-Yield Standouts
Forbes· 19 hours ago“Would you kindly do a piece on high dividend stocks,” a reader asked recently. My favorite high-divided stock at the moment is Pfizer
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
The Motley Fool via AOL· 6 days agoMost big pharma stocks trade well above this mark, putting BMS stock in bargain territory. Which...
3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains
InvestorPlace· 4 hours agoThere are multiple reasons to consider exposure to pharmaceutical stocks for the long-term...
7 Dividend Stocks to Buy Now: June 2024
InvestorPlace· 1 day agoThese dividend stocks to buy now will reward investors with income now and growth as the market breadth expands.
2 Beaten-Down Growth Stocks to Buy Without Hesitation in the 2024 Bull Market
Motley Fool via Yahoo Finance· 13 hours agoManagement also expects that its ongoing cost-cutting efforts will save the business $4 billion this...
Los Angeles Capital Management LLC Grows Stock Holdings in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 19 hours agoLos Angeles Capital Management LLC grew its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 59.6% in the 1st quarter, according to its most recent disclosure ...
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold | The Motley Fool
The Motley Fool· 3 days agoInvestors looking for high-yield dividend stocks to buy now should turn their attention toward the...
Want an Extra $100 in Annual Dividend Income? Invest $1,320 in These 3 High-Yield Stocks
Motley Fool via Yahoo Finance· 2 days agoPfizer have lost more than half their value since the stock peaked in late 2021. In a nutshell,...
Alnylam Pharmaceuticals reports promising heart disease trial data
Invezz· 9 hours agoAlnylam Pharmaceuticals Inc (NASDAQ: ALNY) opened more than 30% up on Monday after reporting...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 3 days agoMore importantly, though, with a forward earnings multiple of only 11.9, the stock's valuation is attractive. Granted, there are some reasons for Pfizer...